Cancer Population Evidence Programme
The Cancer Population Evidence Programme (CPEP) is a flagship programme which brings together evidence on people living with cancer in order that we may better understand their needs now and in the future.
Health and social care provision is changing in the UK. Efficiency savings in the NHS coupled with a growing cancer population mean increased pressure on health services.
In light of these challenges it's really important to demonstrate value, that is, show that service solutions are both cost effective and maximise outcomes for people affected by cancer.
The four areas of the Cancer Population Evidence Programme
Outcomes and experience
Outcomes can refer to:
clinical outcomes of health care interventions
patient reported outcomes
a range of available quality of life and wellbeing measures
The Cancer Population Evidence Programme will demonstrate outcomes and experience at individual, population and service levels. We are also interested in quality of service delivered. It is important to ensure that services are tailored to individual needs and that patients are listened to and engaged in their treatment and aftercare.
It is important to demonstrate that we understand the costs of cancer and that the resources available for cancer services are used effectively. Additional services or funding will be based on evidence and understanding of the costs and benefits associated with them.
There is a pressing need for more economic evidence about the costs and effectiveness of cancer care across the whole pathway. Macmillan is dedicated to ensuring that outcomes for patients can be improved in challenging economic times.
We now know more about people living with cancer than we ever have before and we are using epidemiological data across Macmillan more and more. As new datasets become available we will understand more about the different treatment pathways and link these to patient outcomes and experience.
Effective service solutions
Macmillan is committed to providing effective service solutions to improve the lives of people affected by cancer. We will produce evidence that demonstrates the value of the services we offer and the impact they have. We will understand the effectiveness and efficiency of our service solutions and demonstrate how they affect experience, costs, outcomes and quality.
Bringing it all together and making it happen
The power of the Cancer Population Evidence Programme lies not just in developing the evidence in each of the areas but in bringing this data together to create a complete picture. This will mean we can work with planners, commissioners and decision makers to use the best evidence to meet the needs of people affected be cancer now and in the future.
For more information about the Cancer Population Evidence Programme contact Dr Rebecca Nash – Cancer Population Evidence Programme Manager, Macmillan Cancer Support email@example.com